Search results
Added:
1 year ago
PAP Therapies for HF: What Do the Trials Tell Us?
Added:
4 months ago
Review Article
Added:
5 months ago
Start date:
Jul 02, 2025
.img-row:after {
content: "";
clear: both;
display: table;
}
.img-column {
float: left;
width: 50%;
padding: 5px;
}
@media screen and (max-width: 500px) {
.img-column {
width: 100%;
}
}
Join James Burton (University of Leicester, Leicester, UK), Clara Bonanad (University Clinical Hospital of Valencia, Valencia, ES), Aaron Wong (Princess of Wales Hospital, Bridgend, Wales, UK)…
View more
Added:
11 months ago
Pharmacological Therapy of HFrEF in 2025
Added:
8 months ago
Review Article
Added:
1 month ago
Added:
5 months ago
AHA Scientific Sessions 2025 – Dr Anna Meta Dyrvig Kristensen (Copenhagen University Hospital, Bispebjerg and Frederiksberg, DK) presents an individual patient data meta-analysis examining beta-blocker therapy after myocardial infarction in patients with preserved left ventricular ejection fraction.This comprehensive meta-analysis pooled individual patient data from five randomized controlled…
View more
Added:
1 year ago
In this engaging episode of Masterclass filmed at the ACC, host Dr Harriette Van Spall (McMaster University, Hamilton, CA) sits down with Dr Joseph Hill (UT Southwestern Medical Center, Dallas, TX, US) for a thought-provoking conversation about his career journey, the challenges of medical misinformation, and the critical importance of effective scientific communication.Together, they explore the…
View more
Added:
7 months ago
ESC Congress 2025 - Dr Muthiah Vaduganathan (Brigham and Women’s Hospital, Boston, US) joins us to discuss findings from a trial investigating the lifetime benefits of combination therapy for patients with HFpEF by looking at individual level data from DELIVER, FINEARTS-HF and PARAGON-HF trials.Interview Questions:1. What is the reasoning behind the trial?2. What was the study design and patient…
View more